Adaptimmune Therapeutics plc (473A) — Free Cash Flow Generation Index
Adaptimmune Therapeutics plc (473A) has a Free Cash Flow Generation Index of 0.98x as of June 2024. Free cash flow of €46.65 Million represents 1% of operating cash flow (€47.40 Million). Read 473A total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Adaptimmune Therapeutics plc Free Cash Flow Generation Index (2021–2021)
Historical FCF Generation Index trend for Adaptimmune Therapeutics plc across 1 annual periods. Explore Adaptimmune Therapeutics plc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Adaptimmune Therapeutics plc (2021–2021)
Year-by-year Free Cash Flow Generation Index for Adaptimmune Therapeutics plc. For the full company profile including market capitalisation, see 473A market cap.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.18x | €1.95 Million | €10.73 Million | €8.57 Million | — |